- Home
- SVRA vs ULCC Comparison
SVRA vs ULCC Comparison
Compare SVRA & ULCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- ULCC
- Stock Information
- Founded
- SVRA N/A
- ULCC 1994
- Country
- SVRA United States
- ULCC United States
- Employees
- SVRA N/A
- ULCC N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- ULCC Air Freight/Delivery Services
- Sector
- SVRA Health Care
- ULCC Consumer Discretionary
- Exchange
- SVRA Nasdaq
- ULCC Nasdaq
- Market Cap
- SVRA 739.1M
- ULCC 839.6M
- IPO Year
- SVRA N/A
- ULCC 2021
- Fundamental
- Price
- SVRA $3.82
- ULCC $5.81
- Analyst Decision
- SVRA Strong Buy
- ULCC Hold
- Analyst Count
- SVRA 5
- ULCC 11
- Target Price
- SVRA $12.00
- ULCC $5.30
- AVG Volume (30 Days)
- SVRA 1.3M
- ULCC 2.9M
- Earning Date
- SVRA 11-07-2024
- ULCC 10-24-2024
- Dividend Yield
- SVRA N/A
- ULCC N/A
- EPS Growth
- SVRA N/A
- ULCC N/A
- EPS
- SVRA N/A
- ULCC N/A
- Revenue
- SVRA N/A
- ULCC $3,612,000,000.00
- Revenue This Year
- SVRA N/A
- ULCC $6.46
- Revenue Next Year
- SVRA N/A
- ULCC $14.87
- P/E Ratio
- SVRA N/A
- ULCC N/A
- Revenue Growth
- SVRA N/A
- ULCC N/A
- 52 Week Low
- SVRA $3.12
- ULCC $2.79
- 52 Week High
- SVRA $5.70
- ULCC $8.33
- Technical
- Relative Strength Index (RSI)
- SVRA 35.17
- ULCC 75.23
- Support Level
- SVRA $3.77
- ULCC $4.90
- Resistance Level
- SVRA $4.33
- ULCC $5.49
- Average True Range (ATR)
- SVRA 0.22
- ULCC 0.30
- MACD
- SVRA -0.07
- ULCC 0.09
- Stochastic Oscillator
- SVRA 9.28
- ULCC 81.09
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About ULCC Frontier Group Holdings Inc.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers.